VERTEX PHARMACEUTICALS INC / MA Noncontrolling Interest, Increase from Sale of Parent Equity Interest
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Noncontrolling Interest, Increase from Sale of Parent Equity Interest of $164.32 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-15.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest · last filed 2018-02-15
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, increase from sale of parent equity interest for fiscal 2015 was $164.32M, a 547.76% increase from fiscal 2014.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, increase from sale of parent equity interest for fiscal 2014 was $25.37M, a 44.18% decline from fiscal 2013.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, increase from sale of parent equity interest for fiscal 2013 was $45.45M.
| Period end | Noncontrolling Interest, Increase from Sale of Parent Equity Interest 12 month |
|---|---|
| 2015-12-31 | $164.32M 10-K · filed 2018-02-15 |
| 2014-12-31 | $25.37M 10-K · filed 2017-02-23 |
| 2013-12-31 | $45.45M 10-K · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |